INDEGENE
Back to Income Statement
|
INDEGENE Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹337 Cr | ₹266 Cr | ₹165 Cr | ₹149 Cr | ₹-6.30 Cr |
What is the latest Consolidated Net Profit of INDEGENE ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹337 Cr |
Mar2023 | ₹266 Cr |
Mar2022 | ₹165 Cr |
Mar2021 | ₹149 Cr |
Mar2020 | ₹-6.30 Cr |
How is Consolidated Net Profit of INDEGENE Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹337 Cr | 26.53 | |
Mar2023 | ₹266 Cr | 61.51 | |
Mar2022 | ₹165 Cr | 10.28 | |
Mar2021 | ₹149 Cr | Positive | |
Mar2020 | ₹-6.30 Cr | - |
Compare Consolidated Net Profit of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,346.4 Cr | -3.8% | 5.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -3.8% |
5.3% |
|
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses